Clinical Study to Evaluate the RxSight Light Adjustable Lens With the Light Delivery Device in Subjects With Preoperative Corneal Astigmatism

Inclusion Criteria: * Must sign a written Informed Consent form and be willing to undergo cataract surgery for the bilateral implantation of the RxLAL. * Greater than the age of 40 on the day the cataract surgery is performed. * Preoperative keratometric cylinder of \>=0.50 D and \<=4.00 D in both eyes. * Cataract causing reduction in best corrected distance visual acuity (BCDVA) to a level of 20/32 or worse with or without glare source in both eyes. * Willing and able to comply with the requirements for study specific procedures and visits. Exclusion Criteria: * Zonular laxity or dehiscence. * Age-related macular degeneration involving the presence of geographic atrophy or soft drusen. * Retinal degenerative disorder or macular disorder (other than mild macular degeneration) that is expected to cause future vision loss. * History of uveitis * Keratoconus or suspected of having keratoconus. * Previous corneal or intraocular surgery, except eyes with previous pterygium excision are permitted as long as the pterygium did not extend more than 2mm onto the cornea from the limbus. * Serious co-morbid conditions that in the judgement of the investigator makes inclusion in the study not in the best interest of the subject. * Subjects taking systemic medications that may increase sensitivity to UV light. * Subjects taking a systemic medication that is considered toxic to the retina such as tamoxifen. * History of ocular herpes simplex virus * History of congenital color vision defect